Novel 3,9-Diaza-Spiro[5,5]Undecane Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
申请人:Eriksen Birgitte L.
公开号:US20090111841A1
公开(公告)日:2009-04-30
This invention relates to novel 3,9-diaza-spiro[5.5]undecane derivatives useful as monoamine neurotransmitter re-uptake inhibitors.
In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
3,9-diaza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
申请人:Neurosearch A/S
公开号:US07943630B2
公开(公告)日:2011-05-17
This invention relates to novel 3,9-diaza-spiro[5.5]undecane derivatives useful as monoamine neurotransmitter re-uptake inhibitors.
In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
NOVEL 3,9-DIAZA-SPIRO[5.5]UNDECANE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS
申请人:NeuroSearch A/S
公开号:EP1917264A1
公开(公告)日:2008-05-07
US7943630B2
申请人:——
公开号:US7943630B2
公开(公告)日:2011-05-17
[EN] NOVEL 3,9-DIAZA-SPIRO[5.5]UNDECANE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS<br/>[FR] NOUVEAUX DERIVES 3,9-DIAZA-SPIRO[5.5]UNDECANE ET LEUR UTILISATIN EN TANT QU'INHIBITEURS DU RECAPTAGE DU NEUROTRANSMITTEUR MONOAMINE
申请人:NEUROSEARCH AS
公开号:WO2007000463A1
公开(公告)日:2007-01-04
[EN] This invention relates to novel 3,9-diaza-spiro[5.5]undecane derivatives useful as monoamine neurotransmitter re-uptake inhibitors. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention. [FR] La présente invention concerne de nouveaux dérivés 3,9-diaza-spiro[5.5]undécane utiles en tant qu'inhibiteurs du recaptage du neurotransmetteur monoamine. D'autres aspects de l'invention concernent l'utilisation de ces composés dans le cadre d'un procédé de traitement ainsi que des compositions pharmaceutiques comprenant les composés selon l'invention.